Test the assumption
Test this assumption: “If the tasks stay the same, moving delivery is only a calendar edit.” A task description says what to produce. A schedule also records approval limits, staff availability, and handoff conditions. Those commitments can fail even when every task remains accurately described. Preserve useful wording, but check the conditions that make the new date feasible. A later date can reduce deadline pressure while creating a different constraint violation.
A later date can still fail
Suppose a package is complete on Thursday for Friday delivery. Its approval is valid through Friday only. Move delivery to Monday: the writing and packaging tasks still describe the correct work, yet the handoff now lacks valid approval. Arrange renewed approval and schedule it before Monday’s handoff. If renewal cannot finish in time, Monday is infeasible. Editing every task would add noise; changing only the milestone would conceal the blocker.
Check the affected boundaries
Keep the review bounded: start at the delivery boundary and follow actual prerequisites backward. Check whether the new date changes each prerequisite’s required finish, validity period, or reserved capacity. Include external commitments: the task list may omit the recipient’s working hours or a supplier’s booking limits. Record the old commitment, the new requirement, and who must confirm it. Recalculate dates affected by those relationships and retain unrelated tasks. At the handoff, require both completed work and valid authorization; task completion alone does not establish readiness.
Hypothetical boundary: the daily cutoff
Consider a new, explicitly hypothetical case: Monday delivery is proposed for 16:00, but the recipient accepts handoffs only until 15:00 local time. The calendar date looks acceptable while the actual handoff falls outside the receiving window. Decision rule: keep that timing only if the recipient confirms an exception; otherwise choose the next accepted window and recheck affected commitments. These examples are illustrative, not reported test results. ABOLTUS remains in development.